Dihydroergocryptine

NERVOUS SYSTEM

Key facts

Dihydroergocryptine is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including HTR2B, Htr7 and Htr7.

• Molecular targets: HTR2B, Htr7 and Htr7 (3 listed in DrugCentral).
• ATC code: N04BC03 (Dopamine agonists).
• Molecular formula: C32H43N5O5; molecular weight 577.73 g/mol.

Mechanism & targets

Molecular targets (3)

Target	Gene	Action	Activity
5-hydroxytryptamine receptor 2B	HTR2B	agonist	Ki 7.48
5-hydroxytryptamine receptor 7	Htr7	antagonist	Ki 7.00
5-hydroxytryptamine receptor 7	Htr7	antagonist	Ki 6.50

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
N04BC03	NERVOUS SYSTEM › ANTI-PARKINSON DRUGS › DOPAMINERGIC AGENTS › Dopamine agonists

Chemical structure

• Molecular formula: C₃₂H₄₃N₅O₅
• Molecular weight: 577.73 g/mol
• CAS number: 25447-66-9
• InChIKey: PBUNVLRHZGSROC-VTIMJTGVSA-N
• PubChem CID: 114948

CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](CC5=CNC6=CC=CC4=C56)N(C)C3)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Dihydroergocryptine work?

Its molecular targets in DrugCentral include HTR2B (agonist), Htr7 (antagonist) and Htr7 (antagonist).

What is the chemical formula of Dihydroergocryptine?

Dihydroergocryptine has the molecular formula C32H43N5O5 and a molecular weight of 577.73 g/mol.

Sources

• DrugCentral drug card 4420 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1743263 — compound record and bioactivity
• PubChem CID 114948 — chemical identifiers
• DrugBank DB13385 — drug record
• FDA UNII 67V3FSL2GL — substance identity
• DailyMed: FDA labels for Dihydroergocryptine — current prescribing information (label search)
• UniProt P41595 (HTR2B) — target protein

How this page is built: methodology · editorial policy & corrections.